Most Clicked StoriesMore >


Smith & Nephew's chief financial officer steps down

AdvaMed SmartBrief | Jan 13, 2017

Julie Brown left her post Wednesday as chief financial officer and director of Smith & Nephew, the company confirmed. RTT News (01/12) London South East (U.K.) (01/12)


Boston Scientific CEO forecasts earnings, sales growth for this year

AdvaMed SmartBrief | Jan 11, 2017

Integra LifeSciences to pay $204M for Derma Sciences

AdvaMed SmartBrief | Jan 12, 2017

Mortara Instrument to be acquired by Hill-Rom in $330M deal

AdvaMed SmartBrief | Jan 11, 2017

Discussion paper on lab-developed test regulation issued by FDA

AdvaMed SmartBrief | Jan 16, 2017

CES 2017: Medical technologies you need to know

AdvaMed SmartBrief | Jan 10, 2017

CMS to cover therapeutic continuous glucose monitors

AdvaMed SmartBrief | Jan 16, 2017

OrthoAccel gets $15M boost, announces management changes

AdvaMed SmartBrief | Jan 13, 2017

ConforMIS gets $50M boost, files shelf registration statement

AdvaMed SmartBrief | Jan 10, 2017

Brainlab invests in German robotic surgical startup

AdvaMed SmartBrief | Jan 11, 2017


Find AdvaMed SmartBrief Issues by Date:



ADVAMED News More >


Start saving with the AdvaMed Purchasing Group

AdvaMed SmartBrief | Jan 16, 2017

10th Annual FDA/AdvaMed Medical Devices and Diagnostics Statistical Issues Conference

AdvaMed SmartBrief | Jan 16, 2017

Recalls from A to Z: Regulations, Decisions, Procedures, and Best Practices

AdvaMed SmartBrief | Jan 13, 2017

The Digital MedTech Conference

AdvaMed SmartBrief | Jan 12, 2017

PMA Submissions Workshop

AdvaMed SmartBrief | Jan 11, 2017




Sign up for AdvaMed SmartBrief



Designed specifically for manufacturers of medical devices, health care information systems and diagnostic products, AdvaMed SmartBrief is a FREE e-mail newsletter. By providing a summary of the day's most important medical technologies news, AdvaMed SmartBrief saves you time and keeps you smart. Learn more

Recent Poll view more polls


What concerns should medical device companies focus on in the coming year?

Chart.